Clinical Trial Update: Liposomal Bupivacaine for Pain After Lumbar Fusion [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating liposomal bupivacaine for pain after lumbar fusion is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lumbar Degenerative Diseases
• Postoperative Acute Pain

Drugs mentioned

• Exparel (liposomal bupivacaine)

Snippet

Sponsor: Min Li | Conditions: Postoperative Acute Pain, Lumbar Degenerative Diseases | Phase 4 | Status: RECRUITING